LIVER CANCER
Clinical trials for LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER trials appear
Sign up with your email to follow new studies for LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental T-Cell therapy for liver cancer halted early
Disease control TerminatedThis study tested a new treatment called ET140203 T cells for people with advanced liver cancer that had not responded to other therapies. The treatment involved taking a patient's own immune cells, modifying them to target cancer, and giving them back. The study was stopped earl…
Matched conditions: LIVER CANCER
Phase: PHASE1 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 03:19 UTC
-
New combo for tough liver cancer shows promise, but trial ends early
Disease control TerminatedThis small study tested whether adding an experimental drug (VIC-1911) to the standard drug lenvatinib could help people with advanced liver cancer that had stopped responding to lenvatinib alone. Only 5 people were enrolled before the trial was stopped early, so we have very lim…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Liver cancer ablation data collected in large registry
Knowledge-focused TerminatedThis study followed over 1,200 people with liver cancer who had a procedure called microwave ablation, which uses heat to destroy tumors. Researchers collected information on how well the procedure worked and how long patients lived, to help doctors better plan future treatments.…
Matched conditions: LIVER CANCER
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC